| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 668889 | 61665 | DECAPEPTYL TRIMESTRAL 11,25 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE | DECAPEPTYL TRIMESTRAL 11,25 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE, 1 vial + 1 ampolla de disolvente | 11,25 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61665/61665_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61665/61665_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68629 | IPSEN PHARMA S.A.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 667711 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 5 ml | 6 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 667712 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 16,7 ml | 6 mg/ml inyectable 16,7 ml | 45 | 1 | 34 | 1 vial de 16,7 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 667713 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 50 ml | 6 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 669790 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 ml | 5 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 669791 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 670615 | 72377 | BOTOX 200 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE | BOTOX 200 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE , 1 vial | 200 U | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72377/72377_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72377/72377_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16052 | ABBVIE SPAIN, S.L.U. | 2011-04-08 | 1 | 1 | 1 | 2011-04-08 | 2011-04-08 | 1 | 2018-02-14 | View Edit Delete | ||||||||||||
| 665767 | 07404001 | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION, 1 vial de 10 ml | 50 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07404001/07404001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07404001/07404001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2010-03-16 | 1 | 1 | 1 | 2010-03-16 | 2010-03-16 | 0 | 2012-10-11 | View Edit Delete | ||||||||||||
| 665768 | 07404002 | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION, 1 vial de 50 ml | 50 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07404002/07404002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07404002/07404002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2010-03-16 | 1 | 1 | 1 | 2010-03-16 | 2010-03-16 | 0 | 2011-12-02 | View Edit Delete | ||||||||||||
| 665769 | 07404003 | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION, 1 vial de 100 ml | 50 mg/ml inyectable perfusión 100 ml | 45 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07404003/07404003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07404003/07404003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2010-03-16 | 1 | 1 | 1 | 2010-03-16 | 2010-03-16 | 0 | 2012-10-11 | View Edit Delete | ||||||||||||
| 665770 | 07404004 | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION, 1 vial de 200 ml | 50 mg/ml inyectable perfusión 200 ml | 45 | 1 | 34 | 1 vial de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07404004/07404004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07404004/07404004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2010-03-16 | 1 | 1 | 1 | 2010-03-16 | 2010-03-16 | 0 | 2011-12-02 | View Edit Delete | ||||||||||||
| 665771 | 07404005 | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION | FLEBOGAMMA DIF 50 mg/ml SOLUCION PARA PERFUSION, 1 vial de 400 ml | 50 mg/ml inyectable 400 ml | 45 | 1 | 34 | 1 vial de 400 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07404005/07404005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07404005/07404005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2010-03-16 | 1 | 1 | 1 | 2010-03-16 | 2010-03-16 | 0 | 2012-10-11 | View Edit Delete | ||||||||||||
| 665957 | 07404006 | FLEBOGAMMA DIF 100 mg/ml SOLUCION PARA PERFUSION | FLEBOGAMMA DIF 100 mg/ml SOLUCION PARA PERFUSION, 1 vial de 50 ml | 100 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07404006/07404006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07404006/07404006_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2011-03-16 | 1 | 1 | 1 | 2011-03-16 | 2011-03-16 | 1 | 2011-11-22 | View Edit Delete | ||||||||||||
| 665958 | 07404007 | FLEBOGAMMA DIF 100 mg/ml SOLUCION PARA PERFUSION | FLEBOGAMMA DIF 100 mg/ml SOLUCION PARA PERFUSION, 1 vial de 100 ml | 100 mg/ml inyectable 100 ml | 45 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07404007/07404007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07404007/07404007_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2011-03-16 | 1 | 1 | 1 | 2011-03-16 | 2011-03-16 | 1 | 2011-11-22 | View Edit Delete | ||||||||||||
| 665959 | 07404008 | FLEBOGAMMA DIF 100 mg/ml SOLUCION PARA PERFUSION | FLEBOGAMMA DIF 100 mg/ml SOLUCION PARA PERFUSION, 1 vial de 200 ml | 100 mg/ml inyectable 200 ml | 45 | 1 | 34 | 1 vial de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07404008/07404008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07404008/07404008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2011-03-16 | 1 | 1 | 1 | 2011-03-16 | 2011-03-16 | 1 | 2011-11-22 | View Edit Delete | ||||||||||||
| 670299 | 60600 | FANHDI 50 UI FVIII/60 UI FVW POR ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | FANHDI 50 UI FVIII/60 UI FVW POR ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 600 UI/500 UI | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60600/60600_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60600/60600_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2001-01-17 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 670349 | 60601 | FANHDI 25 UI FVIII/30 UI FVW POR ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | FANHDI 25 UI FVIII/30 UI FVW POR ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 300 UI/250 UI | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60601/60601_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60601/60601_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2001-01-17 | 0 | 2012-04-10 | View Edit Delete | ||||||||||||
| 670356 | 60602 | FANHDI 100 UI FVIII/120 UI FVW POR ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | FANHDI 100 UI FVIII/120 UI FVW POR ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 1.200 UI/1.000 UI | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60602/60602_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60602/60602_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2001-01-17 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 665780 | 08502001 | MEPACT 4 mg POLVO PARA SUSPENSION PARA PERFUSION | MEPACT 4 mg POLVO PARA SUSPENSION PARA PERFUSION, 1 vial | 4 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08502001/08502001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08502001/08502001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2011-03-01 | View Edit Delete | ||||||||||||
| 665854 | 10622001 | TEPADINA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | TEPADINA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial | 15 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10622001/10622001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10622001/10622001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34778 | ACCORD HEALTHCARE S.L.U. | 2010-10-29 | 1 | 1 | 1 | 2010-10-29 | 2010-10-29 | 0 | 2011-09-23 | View Edit Delete |
Page 245 of 1036, showing 20 records out of 20702 total, starting on record 4881, ending on 4900